From July 1, 2022 to September 30, 2022, the company has repurchased 1,170,002 shares, representing 0.81% for $250 million. With this, the company has completed the repurchase of 11,254,007 shares, representing 7.51% for $2,950 million under the buyback announced on October 21, 2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
216.1 USD | +0.61% | +11.88% | -16.48% |
30/04 | Wall Street: buoyed by Tesla, confident ahead of FOMC meeting | CF |
29/04 | Wall Street: buoyed by Tesla, confident ahead of FOMC meeting | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.48% | 31.28B | |
-4.24% | 86.85B | |
+2.76% | 40.16B | |
+57.86% | 25.27B | |
-13.58% | 15.33B | |
-9.12% | 11.96B | |
-42.56% | 11.61B | |
+6.89% | 8.83B | |
-10.53% | 7.94B | |
+1.55% | 7.58B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Tranche Update on Biogen Inc.'s Equity Buyback Plan announced on October 21, 2020.